- Home
- CDTX vs CBAN Comparison
CDTX vs CBAN Comparison
Compare CDTX & CBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- CBAN
- Stock Information
- Founded
- CDTX 2012
- CBAN 1975
- Country
- CDTX United States
- CBAN United States
- Employees
- CDTX N/A
- CBAN N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- CBAN Major Banks
- Sector
- CDTX Health Care
- CBAN Finance
- Exchange
- CDTX Nasdaq
- CBAN Nasdaq
- Market Cap
- CDTX 259.0M
- CBAN 285.4M
- IPO Year
- CDTX 2015
- CBAN 1998
- Fundamental
- Price
- CDTX $21.69
- CBAN $15.70
- Analyst Decision
- CDTX Strong Buy
- CBAN
- Analyst Count
- CDTX 8
- CBAN 0
- Target Price
- CDTX $38.00
- CBAN N/A
- AVG Volume (30 Days)
- CDTX 164.0K
- CBAN 65.5K
- Earning Date
- CDTX 05-08-2025
- CBAN 04-23-2025
- Dividend Yield
- CDTX N/A
- CBAN 2.92%
- EPS Growth
- CDTX N/A
- CBAN 14.66
- EPS
- CDTX N/A
- CBAN 1.43
- Revenue
- CDTX $1,275,000.00
- CBAN $113,756,000.00
- Revenue This Year
- CDTX N/A
- CBAN $14.62
- Revenue Next Year
- CDTX N/A
- CBAN $6.49
- P/E Ratio
- CDTX N/A
- CBAN $10.95
- Revenue Growth
- CDTX N/A
- CBAN 3.33
- 52 Week Low
- CDTX $10.14
- CBAN $10.88
- 52 Week High
- CDTX $28.42
- CBAN $18.49
- Technical
- Relative Strength Index (RSI)
- CDTX 56.70
- CBAN 55.06
- Support Level
- CDTX $19.97
- CBAN $15.26
- Resistance Level
- CDTX $22.80
- CBAN $15.71
- Average True Range (ATR)
- CDTX 1.37
- CBAN 0.40
- MACD
- CDTX 0.29
- CBAN 0.14
- Stochastic Oscillator
- CDTX 74.55
- CBAN 90.91
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About CBAN Colony Bankcorp Inc.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.